Loading organizations...
§ Private Profile · Holland, MI, USA
Medical device company developing bioactive spinal implants for spinal fusion, using patented HAPPE material.
HAPPE Spine, based in Holland, Michigan, develops and commercializes innovative spinal implants using its patented HAPPE (Hydroxyapatite Porous PEEK) material platform, which enhances PEEK polymers for improved spinal fusion outcomes. The company has seen early adoption, with over 1,500 implants used in more than 800 patients, generating $1 million in revenue in its first full commercial year and achieving a $2.5 million annual run rate. HAPPE Spine closed an oversubscribed $3.35 million Series A funding round in 2021 and operates with fewer than 25 employees. Key figures include President and CEO Andrew Iott, founder Ryan Roeder, and board members Todd Smullen and Doug Snell, with Genesis Innovation Group as a lead investor. HAPPE Spine was founded in 2018 by Ryan Roeder.
HAPPE Spine has raised $3.4M across 1 funding round.
HAPPE Spine has raised $3.4M in total across 1 funding round.
HAPPE Spine has raised $3.4M across 1 funding round. Most recently, it raised $3.4M Series A in November 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 8, 2021 | $3.4M Series A | Genesis Innovation Group | — | Announced |
HAPPE Spine has raised $3.4M in total across 1 funding round.
HAPPE Spine's investors include Genesis Innovation Group.